Yan-Shen Shan Selected Research

2-nitrophenylgalactoside (ONPG)

6/2022

Polyaniline-Based Glyco-Condensation on Au Nanoparticles Enhances Immunotherapy in Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan-Shen Shan Research Topics

Disease

67	Neoplasms (Cancer) 06/2022 - 07/2005
29	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2007
23	Adenocarcinoma 06/2022 - 08/2012
20	Stomach Neoplasms (Stomach Cancer) 11/2021 - 10/2011
12	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2010
12	Carcinogenesis 01/2022 - 11/2014
7	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2019 - 08/2010
5	Disease Progression 01/2022 - 12/2011
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 07/2005
5	Carcinoma (Carcinomatosis) 12/2016 - 09/2005
4	Fibrosis (Cirrhosis) 01/2022 - 04/2013
4	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 05/2007
3	Pancreatic Fistula (Pancreatic Fistulas) 06/2021 - 04/2013
3	Glioma (Gliomas) 04/2021 - 02/2013
3	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 11/2017
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2016
3	Lymphatic Metastasis 01/2021 - 01/2007
2	Cholangiocarcinoma 10/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 06/2022 - 06/2015
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 12/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2021 - 09/2005
2	Wound Infection (Wound Infections) 06/2021 - 07/2010
2	Obesity 06/2021 - 05/2020
2	Microcephaly 05/2021 - 12/2019
2	Neutropenia 10/2020 - 02/2016
2	Pneumoperitoneum 03/2018 - 01/2015
2	Acute Cholecystitis 01/2017 - 09/2005
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2015 - 01/2015
2	Brain Injuries (Brain Injury) 06/2015 - 01/2015
2	Inflammation (Inflammations) 03/2015 - 12/2002

Drug/Important Bio-Agent (IBA)

19	Gemcitabine FDA Link 01/2022 - 10/2007
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2010
13	Fluorouracil (Carac)FDA LinkGeneric 06/2022 - 10/2007
11	Irinotecan (Camptosar)FDA LinkGeneric 06/2022 - 02/2016
11	Leucovorin (Folinic Acid)FDA Link 06/2022 - 12/2011
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 10/2007
6	OsteopontinIBA 03/2015 - 07/2010
5	CytokinesIBA 06/2022 - 07/2010
5	Messenger RNA (mRNA)IBA 01/2022 - 11/2013
5	Protein Isoforms (Isoforms)IBA 05/2021 - 07/2005
5	EnzymesIBA 01/2020 - 09/2011
5	Small Interfering RNA (siRNA)IBA 01/2018 - 11/2014
4	CateninsIBA 02/2022 - 06/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	Therapeutic UsesIBA 10/2021 - 10/2011
4	Indicators and Reagents (Reagents)IBA 12/2018 - 08/2007
3	Cyclin D1IBA 02/2022 - 08/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2017
3	AntigensIBA 01/2022 - 07/2018
3	PlatinumIBA 07/2021 - 01/2016
3	Complementary DNA (cDNA)IBA 01/2020 - 01/2015
3	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 04/2010
3	Interleukin-8 (Interleukin 8)IBA 01/2019 - 09/2016
3	Everolimus FDA Link 11/2017 - 12/2016
2	Glycogen Synthase KinasesIBA 10/2022 - 03/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2019
2	Matrix Metalloproteinases (MMPs)IBA 10/2022 - 01/2019
2	N-Methylaspartate (NMDA)IBA 10/2022 - 06/2015
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Monomeric GTP-Binding ProteinsIBA 01/2022 - 05/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2014
2	MethyltransferasesIBA 01/2022 - 10/2017
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2021 - 01/2020
2	Vascular Endothelial Growth Factor CIBA 01/2021 - 01/2020
2	Factor X (Stuart Factor)IBA 01/2021 - 08/2012
2	Histone Deacetylase InhibitorsIBA 01/2021 - 10/2011
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 11/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 08/2012
2	Codon (Codons)IBA 05/2019 - 01/2016
2	Platelet-Derived Growth FactorIBA 01/2019 - 05/2015
2	AgarIBA 01/2019 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 01/2013
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2019 - 12/2018
2	Carcinoembryonic AntigenIBA 01/2019 - 07/2018
2	MTOR InhibitorsIBA 11/2017 - 11/2017
2	TensinsIBA 11/2017 - 03/2016
2	Phosphotransferases (Kinase)IBA 11/2017 - 10/2007
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2017 - 03/2016
2	NestinIBA 09/2016 - 01/2015
2	Memantine (Namenda)FDA Link 06/2015 - 01/2015
2	IntegrinsIBA 05/2015 - 10/2007
2	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 04/2015 - 01/2015
2	MucinsIBA 12/2014 - 12/2007
2	Cadherins (E-Cadherin)IBA 01/2014 - 04/2010

Therapy/Procedure

20	Therapeutics 06/2022 - 01/2006
15	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
7	Pancreaticoduodenectomy 06/2021 - 09/2005
5	Immunotherapy 10/2022 - 04/2019
3	Neoadjuvant Therapy 01/2022 - 09/2014
3	Induction Chemotherapy 01/2022 - 12/2011
3	Length of Stay 06/2021 - 01/2006
3	Lymph Node Excision (Lymph Node Dissection) 06/2019 - 01/2007
2	Lasers (Laser) 10/2022 - 07/2010
2	Chemoradiotherapy 01/2022 - 12/2011
2	Adjuvant Chemoradiotherapy 01/2021 - 11/2015
2	Pancreatectomy 10/2020 - 04/2013
2	Laparoscopic Cholecystectomy 01/2017 - 09/2005
2	Minimally Invasive Surgical Procedures 11/2014 - 02/2014
2	Induced Hyperthermia (Thermotherapy) 11/2014 - 02/2014